Home › Trial NCT00049517
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
- Trial IDNCT00049517
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorEastern Cooperative Oncology Group
- Enrollment657
- Start date2002-12-19
- ConditionsLeukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.